CHU Dupuytren

Patients diagnosed with ALS receive a multidisciplinary evaluation every 3 months. In addition, we provide medical, social and home support. To share our expertise regarding care for ALS patients, we provide training sessions for medical and paramedical staff, and organise a symposium with other French ALS Centers. Our research interests include epidemiology, cognition and nutrition. To this extent, we establish internal and multicenter research protocols and collaborate with the pharmaceutical industry in therapeutic research.


2 Avenue Martin Luther King, Limoges, France


Philippe Couratier

Professor of Neurology

Professor Philippe Couratier is Neurologist in the University Hospital of Limoges. After […]

Philippe Couratier
Current trials
In preparation
Phase iii


Platform trial
MAGNET is an innovative clinical platform trial in which multiple treatments for ALS are investigated simultaneously.
Read more
Phase iii


Industry trial
This trial will evaluate the efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment for people with ALS.
Read more